carbazilquinone has been researched along with Bone Cancer in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoh, S | 1 |
| Isayama, T | 1 |
| Yoshitake, K | 1 |
| Johzima, H | 1 |
| Ikari, N | 1 |
| Ogata, K | 1 |
1 other study available for carbazilquinone and Bone Cancer
| Article | Year |
|---|---|
[Post-operative intra-arterial chemotherapy for high grade malignant musculoskeletal sarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carbazilquinone; Chemotherapy, Adjuv | 1993 |